A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival ...
In a world first, a teenager with sickle cell disease achieved complete remission after an experimental gene therapy at Necker Children’s Hospital in Paris, researchers say. People with sickle-cell ...
The National Comprehensive Cancer Network ® (NCCN ®) announced today the publication of new NCCN Guidelines for Patients ®: Anemia and Neutropenia, Low Red and White Blood Cell Counts funded by the ...
Aplastic anemia, a rare condition, disrupts blood cell production due to bone marrow failure. It impacts patients physically and emotionally, requiring lifestyle changes and precautions to manage the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback